Airway Management Devices Market Trends and Analysis by 2028

[Research Report] The airway management devices market was valued US$ 1,944.88 million in 2021; it is expected to grow at a CAGR of 6.9% from 2022 to 2028.  

Airway management is a process of assessment, planning, and medical procedures required to restore or maintain ventilation or breathing of the patient. An extensive range of devices is available for airway management. Depending on the criticality of the condition, different types of airway management devices are used by medical professionals.

The airway management devices market is segmented based on product, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the world's leading market players.    

Market Insights

Rising Prevalence of Respiratory Disorders

Chronic respiratory diseases are among the most prevalent noncommunicable diseases worldwide due to the increase in the noxious environment and occupational and behavioral inhalation. This spectrum of diseases includes chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis (such as silicosis and asbestosis). According to the World Health Organization (WHO), COPD is the third leading cause of death globally. In 2019, ~3.23 million people died globally due to COPD. As per the Office of Disease Prevention and Health Promotion, ~14.8 million adults in the US were diagnosed with COPD in 2020. The National Health Service stated that ~1.17 million people in the UK were diagnosed with COPD in 2021, i.e., ~1.9% of the total population.

Published Report - Airway Management Devices Market: Strategic Insights

As per the WHO report, asthma affected 262 million people globally and caused 455,000 deaths in 2019. Moreover, in 2019, asthma resulted in 439,000 hospitalizations and an estimated 1.3 million visits in the US. Hence, the rising prevalence of respiratory disorders is driving the global demand for airway management devices.

Additionally, there is a constant surge in the number of hospitals, ambulatory surgical centers, intensive care units, and clinics, creating demand for airway management devices.                     

Increasing New Product Launches

The increasing prevalence of various chronic disorders, such as asthma, COPD, cystic fibrosis, and emphysema, among a large population globally, has fueled new product developments, product launches, and approvals on a global level. Additionally, major market players are involved in research and development activities to ensure the innovation and development of efficient products. Some of the recent product launches and developments are as follows:

• In July 2022, Verathon announced the release of the BFlex 2.8 Single-use Bronchoscope. BFlex single-use bronchoscopes are designed specifically for the critical needs of the ICU, OR, and ED. The BFlex 2.8 is Verathon's first single-use pediatric bronchoscope and delivers the drivability and image quality needed for pediatric bronchoscopies, airway management, and lung isolation procedures.
• In May 2021, Olympus Corporation received FDA 510(k) clearance for its Airway Mobilescopes—MAF-TM2, MAF-GM2, and MAF-DM2—enabling healthcare providers to perform a variety of upper and lower airway management procedures.
• In May 2021, Medtronic launched the SonarMed airway monitoring system to continuously check any endotracheal tube (ETT) obstruction and position for neonates and infants. It is the first and only device of its kind. The SonarMed airway monitoring system utilizes acoustic technology to check for ETT obstruction and verify position in real-time, giving clinicians vital information required to make more informed, life-saving decisions for their patients.
• In May 2021, VivaSight 2 DLT was launched by Ambu. It is a sterile, single-use double-lumen endobronchial tube that isolates the left or right lung of a patient in one lung ventilation (OLV) procedures.
• In April 2021, Smiths Medical launched the Acapella choice blue vibratory PEP therapy system, which removes secretions in patients with cystic fibrosis, COPD, asthma, lung diseases with secretory problems, and atelectasis.

Thus, the increase in product development, launches, and other strategic collaborations among market players is likely to drive the airway management devices market in the near future.

Product Insights            

Based on product, the global airway management devices market is segmented into infraglottic devices, supraglottic devices, resuscitators, laryngoscopes, and others. In 2021, the infraglottic devices segment held the largest share of the market. However, the supraglottic devices segment is expected to grow at the highest CAGR during 2022–2028.

With improvement in monitoring techniques and the enhanced safety profile of supraglottic airway devices, the indications for using supraglottic airway devices are growing. With the availability of devices having higher seal pressures, their use in laparoscopic surgeries, obstetrics, obese patients, in a prone position, during cardiopulmonary resuscitation, and as a bridge to extubation (Bailey's maneuver) has been rising. A wide array of supraglottic airway devices is available, each claiming superiority over the other for specific indications. For instance, the Shiley laryngeal mask (Shiley LM) features an integrated inflation tube and airway shaft to facilitate product insertion and reduce the chance of tube occlusion when patients bite down. In addition to providing higher seal pressure, some newer devices have additional useful features, such as an integrated pilot cuff with an indicator to help maintain the acceptable range of intra-cuff pressure.   

End User Insights

Based on end user, the airway management devices market is segmented into hospitals, ambulatory surgical care centers, and others. The hospitals segment held the largest market share in 2021. However, the ambulatory surgical care centers (ASCs) segment is expected to be the largest shareholder in the market by 2028 due to high-quality care, cost-effective treatment prices, and expanding access.

Factors such as comfort, patient satisfaction, professionalism, and reliable services are driving the airway management devices market for ASCs. As per a survey conducted by the US Department of Health and Human Services, 98% of people are satisfied with their experience with ASCs. ASCs offer cost-effective services and a convenient environment that is less stressful than many hospitals. Patients in an ASC visit on the day of their surgery, have their surgery in a fully equipped operating room, and recover under the care of professional healthcare staff without getting hospital admission.

Product launches and mergers and acquisitions are the highly adopted strategies by the players operating in the global airway management devices market. A few of the recent key product developments are listed below:

• In January 2022, ICU medical acquired Smiths Medical business from Smiths Group plc. This will create more opportunities for the medical segment of the company.
• In May 2021, Teleflex entered into a definitive agreement with Medline Industries Inc. to sell its certain product lines within the global respiratory product portfolio.
• In May 2021, Medline announced that it had signed a definitive agreement with Teleflex Incorporated to acquire selected assets under the Hudson RCI brand s.

The COVID-19 pandemic increased patient admissions to emergency and intensive care units. The patients with low oxygen level and severe respiratory infections required airway management devices for the treatment of respiratory distress. The demand for tracheostomy and laryngoscopy increased, which boosted the growth of the market. The coronavirus disease resulted in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that led to hypoxemia among large patient which requires airway management for the treatment. The Society for Airway Management (SAM) was created by the American Society of Anesthesiologists Task Force to optimize airway management and reduce the risk of exposure. Thus, the COVID-19 pandemic increased the overall demand for airway management devices.

Airway Management Devices

Published Report - Airway Management Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Published Report - Airway Management Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Airway Management Devices – Market Segmentation

Based on product, the global airway management devices market is segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, and others. The infraglottic devices segment held the largest share of the market in 2021; however, the supraglottic devices segment is anticipated to register the highest CAGR of 7.2% during the forecast period. Based on end user, the global airway management devices market is segmented into hospitals, ambulatory surgical care centers, and others. The hospital segment accounted for the largest share of the airway management devices market in 2021.

Based on geography, the global airway management devices market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa (MEA), and South & Central America. The airway management devices market in North America is further segmented into the US, Canada, and Mexico. The Europe airway management devices market is subsegmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The airway management devices market in Asia Pacific is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The airway management devices market in the MEA is further segmented into South Africa, Saudi Arabia, the UAE, and the Rest of the MEA. The airway management devices market in South & Central America is subsegmented into Brazil, Argentina, and the Rest of South & Central America.

Teleflex Incorporated; Smiths Medical; Medtronic; Intersurgical Ltd; Ambu A/S; Medline Industries, Inc.; Koninklijke Philips N.V.; Armstrong Medical; Mercury Medical; and Cook Medical LLC are among the leading companies operating in the airway management devices market.